Director Regulatory Affairs
Deciphera Pharmaceuticals
Director Regulatory Affairs
Deciphera Pharmaceuticals
Develops kinase inhibitors for cancer.
The Director, Regulatory Affairs will join a group of highly motivated regulatory professionals and play a critical role in shaping cohesive regulatory strategies across Deciphera’s product pipeline.
The Director will operate as a strategic regulatory lead, developing and implementing global regulatory strategies for oncology programs from early development through post-marketing. This role will provide expert guidance to cross-functional teams, drive regulatory submissions, and ensure compliance with applicable regulations and industry standards.
Key Responsibilities
Regulatory Strategy & Leadership
Regulatory Submissions & Compliance
Cross-Functional Collaboration
Leadership & People Management
Process Improvement & Innovation
Other duties and responsibilities as assigned
Preferred Capabilities
Deciphera believes in providing a fair, equitable, and competitive compensation and benefits package to all employees. Our base salary is just one component of Deciphera’s competitive total rewards strategy that also includes annual performance bonus, a long-term incentive plan, full range of benefits and other incentive compensation plans (if applicable)
Benefits:
EQUAL EMPLOYMENT OPPORTUNITY INFORMATION
Deciphera is committed to equal employment opportunity and values diversity. To ensure that we comply with reporting requirements, we invite you complete the confidential survey at the end of this application. Providing this information is optional. It will not be accessible or used in the hiring process, and has no effect on your opportunity for employment. This information will also be treated confidentially. We are committed to make all hiring decisions and other employment decisions on a non-discriminatory basis.
Compensation: 196000 to 245000 (USD) (YEARLY)
Develops kinase inhibitors for cancer.
Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing cancer medicines. It uses a proprietary switch-control kinase inhibitor platform and deep kinase biology expertise to create targeted therapies for various cancers. The company advances drug candidates through research, clinical trials, and regulatory approval, then brings approved medicines to market and seeks partnerships or licensing deals to expand its reach. Its competitive edge comes from its unique switch-control kinase inhibitors and deep biology know-how, which aim to deliver precision treatments in oncology. The company’s goal is to improve the lives of cancer patients by delivering effective targeted therapies.
Explore more opportunities at Deciphera Pharmaceuticals